Daniel Sheinson

6.0k total citations
37 papers, 431 citations indexed

About

Daniel Sheinson is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Sheinson has authored 37 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Sheinson's work include Lung Cancer Treatments and Mutations (7 papers), Multiple Sclerosis Research Studies (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Daniel Sheinson is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Multiple Sclerosis Research Studies (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Daniel Sheinson collaborates with scholars based in United States, Switzerland and France. Daniel Sheinson's co-authors include William B. Wong, Stacey Kowal, Carmen D. Ng, Yang Meng, Jacqueline McBride, Craig S. Meyer, Ibrahim M. Abbass, Wendy Meiring, Jarad Niemi and Jorge A. Tavel and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Daniel Sheinson

36 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Sheinson United States 13 105 91 77 76 71 37 431
R. Babela Slovakia 6 72 0.7× 33 0.4× 60 0.8× 22 0.3× 77 1.1× 23 452
Nahila Justo Sweden 10 28 0.3× 150 1.6× 79 1.0× 18 0.2× 62 0.9× 21 418
Marco Mariani Italy 12 88 0.8× 46 0.5× 65 0.8× 36 0.5× 34 0.5× 30 388
Joshua C. Pritchett United States 13 225 2.1× 257 2.8× 63 0.8× 47 0.6× 25 0.4× 39 479
H. Frick Switzerland 7 103 1.0× 276 3.0× 51 0.7× 107 1.4× 12 0.2× 10 392
Naftali Busakhala Kenya 11 92 0.9× 234 2.6× 72 0.9× 105 1.4× 17 0.2× 35 354
Angela Y. Wong United States 12 174 1.7× 165 1.8× 189 2.5× 110 1.4× 12 0.2× 20 599
Aatish Patel United Kingdom 12 54 0.5× 160 1.8× 170 2.2× 36 0.5× 20 0.3× 20 654
Javier Louro Spain 12 28 0.3× 241 2.6× 59 0.8× 43 0.6× 21 0.3× 30 400
Baris Deniz United States 10 245 2.3× 47 0.5× 35 0.5× 71 0.9× 44 0.6× 25 412

Countries citing papers authored by Daniel Sheinson

Since Specialization
Citations

This map shows the geographic impact of Daniel Sheinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Sheinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Sheinson more than expected).

Fields of papers citing papers by Daniel Sheinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Sheinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Sheinson. The network helps show where Daniel Sheinson may publish in the future.

Co-authorship network of co-authors of Daniel Sheinson

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Sheinson. A scholar is included among the top collaborators of Daniel Sheinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Sheinson. Daniel Sheinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leal, Ticiana, Qing Zhang, Daniel Sheinson, et al.. (2024). ALK testing patterns in early-stage non-small cell lung cancer: A real-world evidence study.. Journal of Clinical Oncology. 42(16_suppl). 8074–8074. 1 indexed citations
2.
3.
Gatwood, Justin, et al.. (2024). Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma. Journal of Medical Economics. 27(1). 738–745. 1 indexed citations
4.
5.
Vidal, Gregory A., Neha Jain, Aaron J. Fisher, et al.. (2023). Practice- and provider-level inequities in next-generation sequencing (NGS) testing by race/ethnicity for patients (pts) with advanced non-small cell lung cancer (aNSCLC) treated in the community setting.. Journal of Clinical Oncology. 41(16_suppl). 6508–6508. 1 indexed citations
6.
7.
Pardo, Gabriel, et al.. (2022). Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis. Neurology and Therapy. 11(1). 337–351. 9 indexed citations
8.
9.
Sheinson, Daniel, et al.. (2021). Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing. JCO Oncology Practice. 17(11). e1774–e1784. 25 indexed citations
10.
Sheinson, Daniel, et al.. (2021). PIN67 Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods. Value in Health. 24. S118–S118. 1 indexed citations
11.
Exuzides, Alex, Daniel Sheinson, Páris Sidiropoulos, et al.. (2021). Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder. Journal of the Neurological Sciences. 427. 117530–117530. 16 indexed citations
12.
Exuzides, Alex, et al.. (2021). Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database. Journal of Medical Economics. 24(1). 581–588. 3 indexed citations
13.
Wallick, Christopher J., et al.. (2021). Healthcare Resource Use and Burden Associated with Influenza Transmission Among Household Members with a Primary Infection: Commercial Claims Data Analysis. ClinicoEconomics and Outcomes Research. Volume 13. 335–342. 4 indexed citations
14.
Sheinson, Daniel, et al.. (2020). Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization. Advances in Therapy. 38(2). 1212–1226. 5 indexed citations
15.
Sheinson, Daniel, William B. Wong, Ning Wu, & Aaron S. Mansfield. (2020). Impact of delaying initiation of anaplastic lymphoma kinase inhibitor treatment on survival in patients with advanced non-small-cell lung cancer. Lung Cancer. 143. 86–92. 14 indexed citations
16.
Moshfeghi, Andrew A., et al.. (2020). <p>Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical Practice</p>. Clinical ophthalmology. Volume 14. 3651–3659. 26 indexed citations
17.
Sheinson, Daniel, et al.. (2020). HER2-Positive Metastatic Breast Cancer: A Retrospective Cohort Study of Healthcare Costs in the Targeted-Therapy Age. Advances in Therapy. 37(4). 1632–1645. 8 indexed citations
18.
Wong, William B. & Daniel Sheinson. (2019). PCN18 INDIRECT TREATMENT COMPARISON OF ALECTINIB VS. BRIGATINIB IN ALK+ NON-SMALL CELL LUNG CANCER (NSCLC). Value in Health. 22. S59–S59. 1 indexed citations
19.
Sheinson, Daniel, et al.. (2018). In vitro assessment of chemotherapy-induced neuronal toxicity. Toxicology in Vitro. 50. 109–123. 16 indexed citations
20.
Sheinson, Daniel, Jarad Niemi, & Wendy Meiring. (2014). Comparison of the performance of particle filter algorithms applied to tracking of a disease epidemic. Mathematical Biosciences. 255. 21–32. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Babela Breakdown of academic impact, for papers by Nahila Justo Breakdown of academic impact, for papers by Marco Mariani Breakdown of academic impact, for papers by Joshua C. Pritchett Breakdown of academic impact, for papers by H. Frick Breakdown of academic impact, for papers by Naftali Busakhala Breakdown of academic impact, for papers by Angela Y. Wong Breakdown of academic impact, for papers by Aatish Patel Breakdown of academic impact, for papers by Javier Louro Breakdown of academic impact, for papers by Baris Deniz
Rankless by CCL
2026